Clinical Pharmacokinetics of Fosfomycin after Continuous Infusion Compared with Intermittent Infusion: a Randomized Crossover Study in Healthy Volunteers

Continuous infusion (CON) of fosfomycin has been proposed as potentially advantageous in certain clinical scenarios. However, no clinical data on the pharmacokinetics (PK) of fosfomycin after CON are available to date. This study aimed to investigate the PK of fosfomycin after CON and compare it wit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: al Jalali, Valentin, Matzneller, Peter, Wulkersdorfer, Beatrix, Chou, Scharon, Bahmany, Soma, Koch, Birgit C. P., Zeitlinger, Markus
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2020
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927804/
https://ncbi.nlm.nih.gov/pubmed/33106259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01375-20
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki